Pharmacy - Antimicrobials News & Articles

521 Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae Antimicrobial Agents and Chemotherapy, March 18, 2013    Clinical Article

522 HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer Inhibitor Elvitegravir and NRTIs Emtricitabine and Tenofovir In Vitro Journal of Acquired Immune Deficiency Syndromes, March 18, 2013    Clinical Article

523 Nephrotoxicity in Patients with Vancomycin Trough Concentrations of 15-20 μg/ml in a Pediatric Intensive Care Unit Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 18, 2013    Clinical Article

524 The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus International Journal of Infectious Diseases, March 15, 2013    Clinical Article

525 Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae Travel Medicine and Infectious Disease , March 15, 2013    Clinical Article

526 Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin MIC>1 mg/L: a matched cohort study Clinical Infectious Diseases, March 15, 2013    Clinical Article

527 Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial The Lancet, March 15, 2013    Clinical Article
Exclusive Author Commentary

528 Effectiveness of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax and P. falciparum Malaria in Young Children in Papua New Guinea Clinical Infectious Diseases, March 15, 2013    Clinical Article

529 Elucidating the Regulon of Multidrug Resistance Regulator RarA in Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, March 15, 2013    Review Article

530 Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses Full Text BMC Infectious Diseases, March 15, 2013    Clinical Article

531 Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial The Lancet Infectious Diseases, March 15, 2013    Clinical Article

532 Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy Antimicrobial Agents and Chemotherapy, March 15, 2013    Clinical Article

533 Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases Full Text PLoS Neglected Tropical Diseases, March 15, 2013    Clinical Article

534 A Cutting-Edge View on the Current State of Antiviral Drug Development Medicinal Research Reviews, March 15, 2013    Clinical Article

535 Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring Antiviral Research , March 15, 2013    Clinical Article

536 Synergistic Effects of Amiodarone and Fluconazole on Candida tropicalis Resistant to Fluconazole Antimicrobial Agents and Chemotherapy, March 15, 2013    Clinical Article

537 Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity Antimicrobial Agents and Chemotherapy, March 15, 2013    Clinical Article

538 Steady-State Pharmacokinetics, Cord Blood Concentrations, and Safety of Ritonavir-Boosted Fosamprenavir in Pregnancy Journal of Acquired Immune Deficiency Syndromes, March 14, 2013    Clinical Article

539 Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral Contraceptives Journal of Acquired Immune Deficiency Syndromes, March 14, 2013    Clinical Article

540 Global Impact of an Educational Antimicrobial Stewardship Program on Prescribing Practice in a Tertiary Hospital Center Clinical Microbiology and Infection, March 14, 2013    Clinical Article

1 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections Cochrane Reviews, March 29, 2013    Review Article

2 Telavancin and Daptomycin activity against methicillin-resistant Staphylococcus aureus strains after vancomycin resistance selection in vitro Journal of Medical Microbiology, April 22, 2013

3 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Clinical Infectious Diseases, April 1, 2013

4 Infective Endocarditis New England Journal of Medicine, April 12, 2013

5 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

6 Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection European Journal of Clinical Pharmacology, April 3, 2013

7 Effect of Azithromycin on Anticoagulation-Related Outcomes in Geriatric Patients Receiving Warfarin Clinical Therapeutics, April 22, 2013

8 Antifungal Therapy for Invasive Aspergillosis U.S. Pharmacist, April 26, 2013    Free full text

9 Infective Endocarditis New England Journal of Medicine, April 24, 2013    Review Article

10 Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, April 23, 2013

11 Update on the Antimicrobial Management of Foot Infections in Patients With Diabetes Clinical Diabetes, April 18, 2013    Free full text    Review Article

12 Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents Clinical Microbiology Reviews, April 4, 2013

13 Is It Time To Replace Vancomycin In The Treatment Of MRSA Infections Clinical Infectious Diseases, April 4, 2013

14 Clinical Trial: Comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole vs. cephalexin alone for treatment of uncomplicated cellulitis: A randomized controlled trial Clinical Infectious Diseases, March 21, 2013

15 Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials International Journal of Antimicrobial Agents, April 23, 2013    Evidence Based Medicine

16 Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections European Journal of Clinical Microbiology & Infectious Diseases, April 5, 2013

17 Tigecycline: an update Diagnostic Microbiology and Infectious Disease, February 5, 2013

18 Effect of adequate single-drug versus combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections. A post hoc analysis of a prospective cohort Clinical Infectious Diseases, April 17, 2013

19 Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies Expert Review of Anti-infective Therapy, April 19, 2013

20 Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia International Journal of Antimicrobial Agents, April 19, 2013